Whole body leucine flux in HIV-infected patients treated with or without protease inhibitors (Q46774522)

25 December 2017

title

Whole body leucine flux in HIV-infected patients treated with or without protease inhibitors (English)

1 reference

25 December 2017

author name string

Magali Prod'homme

1

1 reference

25 December 2017

Cécile Rochon

2

1 reference

25 December 2017

Michèle Balage

3

1 reference

25 December 2017

Henri Laurichesse

4

1 reference

25 December 2017

Igor Tauveron

5

1 reference

25 December 2017

Claude Champredon

6

1 reference

25 December 2017

Philippe Thieblot

7

1 reference

25 December 2017

Jean Beytout

8

1 reference

25 December 2017

Jean Grizard

9

1 reference

25 December 2017

publication date

25 October 2005

1 reference

25 December 2017

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

25 December 2017

volume

290

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

E685-93

1 reference

25 December 2017

Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Acute metabolic acidosis inhibits muscle protein synthesis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Differential responsiveness of protein synthesis and degradation to amino acid availability in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Weight loss and wasting in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Indinavir impairs protein synthesis and phosphorylations of MAPKs in mouse C2C12 myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Measurement of leucine metabolism in man from a primed, continuous infusion of L-[1-3C]leucine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Hyperlipidemia associated with HIV protease inhibitor use: pathophysiology, prevalence, risk factors and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Insulin and amino acids both strongly participate to the regulation of protein metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Nutrition and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Effect of increased protein intake and nutritional status on whole-body protein metabolism of AIDS patients with weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Isolation of aminoacyl-tRNA and its labeling with stable-isotope tracers: Use in studies of human tissue protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Reducing plasma HIV RNA improves muscle amino acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Increased plasma gln and Leu Ra and inappropriately low muscle protein synthesis rate in AIDS wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

Beneficial effects of protease inhibitors on body composition and energy expenditure: a comparison between HIV-infected and AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00067.2005

10.1152/AJPENDO.00067.2005

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017